Michael Ehlers

Biogen has appointed Michael Ehlers as executive vice president of research and development. He will report to CEO George Scangos and will begin his tenure in late May. Ehlers joins Biogen from Pfizer where he served as group senior vice president for biotherapeutics research and development and CSO for the company's Neuroscience and Pain Research Unit. Prior to joining Pfizer in 2010, he was a professor of neurobiology and an investigator at the Howard Hughes Medical Institute at Duke University Medical Center.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The apple has traveled westward and eastward along the Silk Road, according to a new genetic analysis.

In Nature this week: GWAS data used to reposition drugs for psychiatric use, and more.

Genetic disease risk information doesn't always spur people to make healthy lifestyle changes, according to the Associated Press.

A University of California, San Diego-led team has used liquid biopsies to uncover possible treatments for patients with cancers of unknown primary.